Key Facts About Molina Healthcare Stock

By Tamara Parker • Thursday, July 25 15:10 • Permanent Link

Molina Healthcare logged a 12.9% change during today's afternoon session, and is now trading at a price of $325.9 per share. The S&P 500 index moved -0.0%. MOH's trading volume is 2,122,344 compared to the stock's average volume of 541,254.

Molina Healthcare trades -10.94% away from its average analyst target price of $365.92 per share. The 14 analysts following the stock have set target prices ranging from $297.0 to $424.0, and on average have given Molina Healthcare a rating of hold.

If you are considering an investment in MOH, you'll want to know the following:

Molina Healthcare's current price is 86.2% above its Graham number of $175.04, which implies that at its current valuation it does not offer a margin of safety
Molina Healthcare has moved -6.1% over the last year, and the S&P 500 logged a change of 19.6%
Based on its trailing earnings per share of 18.1, Molina Healthcare has a trailing 12 month Price to Earnings (P/E) ratio of 18.0 while the S&P 500 average is 28.21
MOH has a forward P/E ratio of 12.3 based on its forward 12 month price to earnings (EPS) of $26.4 per share
The company has a price to earnings growth (PEG) ratio of 0.94 — a number near or below 1 signifying that Molina Healthcare is fairly valued compared to its estimated growth potential
Its Price to Book (P/B) ratio is 3.97 compared to its sector average of 3.69
Molina Healthcare, Inc. provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces.
Based in Long Beach, the company has 18,000 full time employees and a market cap of $19.23 Billion.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.